NCT05254912View on ClinicalTrials.gov

Photoallergic Potential of 6% Bemotrizinol

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 7, 2022

Primary Completion Date

April 22, 2022

Study Completion Date

April 22, 2022

Conditions
Photoallergic Response
Interventions
DRUG

6% Bemotrizinol in sunscreen formulation

6% Bemotrizinol (BEMT) in a basic sunscreen oil formulation (SU E 101413 85)

DRUG

6% Bemotrizinol in petrolatum

6% Bemotrizinol (BEMT) as a dispersion in petrolatum (SU-E-101413-82)

OTHER

Vehicle

Sunscreen oil vehicle with 10% ethanol as penetration enhancer without BEMT (SU E 101413 91)

Trial Locations (1)

New Jersey

"Eurofins , CRL, Inc."

All Listed Sponsors
lead

DSM Nutritional Products, Inc.

INDUSTRY